Consensus expert opinion on key items in planning and designing clinical trials in geriatric patients
https://doi.org/10.37586/2686-8636-4-2021-398-402
Abstract
The consensus statement provides expert opinion on key items in planning and designing clinical trials for medications that are intended for use mainly or probably in geriatric patients.
About the Authors
O. N. TkachevaRussian Federation
Tkacheva Olga N., MD, PhD, professor, Director
+7(499)187-64-67
D. A. Sychev
Russian Federation
Sychev Dmitry A., MD, PhD, professor RAS, Corresponding Member of RAS, Rector
I. P. Malaya
Russian Federation
Malaya Irina P., MD, PhD, senior researcher, Head of Laboratory Clinical Pharmacology and Pharmacotherapy
+7(985)998-39-83
V. A. Burmistrov
Russian Federation
Burmistrov Viacheslav A., Medical Committee Chair
E. K. Vergazova
Russian Federation
Vergazova Elmira K., MD, PhD, Deputy Head
A. A. Galeeva
Russian Federation
Galeeva Almira A., Director of Clinical Research, Ethics & Medical Affairs
I. G. Gordeev
Russian Federation
Gordeev Ivan G., MD, PhD, professor, Head of the Department of Hospital Therapy № 1
+7(926)534-59-12
V. A. Dmitriev
Russian Federation
Dmitriev Victor A., MD, PhD, General Director
M. V. Zhuravleva
Russian Federation
Zhuravleva Marina V., MD, PhD, professor, Deputy Director of the Clinical Pharmacology Centre, chief freelance specialist - clinical pharmacologist
S. K. Zyryanov
Russian Federation
Zyryanov Sergey K., MD, PhD, professor, Chief of General and Clinical Pharmacology
Yu. V. Kotovskaya
Russian Federation
Kotovskaya Yulia V., MD, PhD, professor, Deputy Director
+7(499)187-78-09
A. V. Naumov
Russian Federation
Naumov Anton V., MD, PhD, professor, Head of Bone and Muscular Diseases Laboratory
S. V. Nedogoda
Russian Federation
Nedogoda Sergei V., MD, PhD, professor, Vice-Chancellor for Regional Health Development and Clinical Affairs, Head of the Department for Internal Diseases
Volgograd
N. K. Runikhina
Russian Federation
Runikhina Nadezhda K., MD, PhD, Deputy Director
+7(499)187-78-09
К. Е. Teplova-Bareisha
Russian Federation
Teplova-Bareisha Ksenia E., Clinical Research Committee Chair
E. V. Frolova
Russian Federation
Frolova Elena V., MD, PhD, professor of Family Medicine Chair
St-Petersburg
+7 (812) 598-52-22
A. L. Khokhlov
Russian Federation
Khokhlov Alexander L., MD, PhD, Corresponding Member of the Russian Academy of Sciences, professor, Head of the Department of the Clinical Pharmacology and Ethical Drugs Utilization UNESCO
Yaroslavl
References
1. Milton J.C., Hill-Smith I., Jackson S.H. Prescribing for older people. BMJ. 2008 Mar 15; 336(7644): 606–9. DOI: 10.1136/ bmj.39503.424653.80. PMID: 18340075; PMCID: PMC2267940.
2. Ушкалова Е.А., Ткачева О.Н., Рунихина Н.К., Чухарева Н.А., Бевз А.Ю. ОСОБЕННОСТИ ФАРМАКОТЕРАПИИ У ПОЖИЛЫХ ПАЦИЕНТОВ. ВВЕДЕНИЕ В ПРОБЛЕМУ. Рациональная Фармакотерапия в Кардиологии. 2016; 12(1): 94–100. https://doi.org/10.20996/1819-6446-2016-12-1-94-100.
3. Dennis G.C. NMA's clinical trials program. J Natl Med Assoc. 1998 Dec; 90(12): 743–4. PMID: 10200084; PMCID: PMC2608433.
4. Малая И.П. Клинические исследования у пожилых: состояние проблемы и современные регуляторные требования. Российский журнал гериатрической медицины. 2021; (1): 97– 104. https://doi.org/10.37586/2686-8636-1-2021-97-104.
5. Cherubini A., Oristrell J., Pla X., Ruggiero C., Ferretti R., Diestre G., Clarfield A.M., Crome P., Hertogh C., Lesauskaite V., Prada G.I., Szczerbinska K., Topinkova E., Sinclair-Cohen J., Edbrooke D., Mills G.H. The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch Intern Med. 2011 Mar 28; 171(6): 550–6. DOI: 10.1001/archinternmed.2011.31. PMID: 21444844.
6. Cherubini A., Del Signore S., Ouslander J., Semla T., Michel J.P. Fighting against age discrimination in clinical trials. J Am Geriatr Soc. 2010 Sep; 58(9): 1791–6. DOI: 10.1111/j.15325415.2010.03032.x. PMID: 20863340.
7. Banzi R., Camaioni P., Tettamanti M., Bertele' V., Lucca U. Older patients are still under-represented in clinical trials of Alzheimer's disease. Alzheimers Res Ther. 2016 Aug 12; 8: 32. DOI: 10.1186/s13195-016-0201-2. PMID: 27520290; PMCID: PMC4982205.
8. Unger J.M., Coltman C.A. Jr., Crowley J.J., Hutchins L.F., Martino S., Livingston R.B., Macdonald J.S., Blanke C.D., Gandara D.R., Crawford E.D., Albain K.S. Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials. J Clin Oncol. 2006 Jan 1; 24(1): 141–4. DOI: 10.1200/ JCO.2005.02.8928. Epub 2005 Dec 5. PMID: 16330670.
9. Ткачева О.Н., Котовская Ю.В., Рунихина Н.К., Фролова Е.В., Наумов А.В., Воробьева Н.М., Остапенко В.С., Мхитарян Э.А., Шарашкина Н.В., Тюхменев Е.А., Переверзев А.П., Дудинская Е.Н. Клинические рекомендации «Старческая астения». Часть 2. Российский журнал гериатрической медицины. 2020; (2): 115– 130. https://doi.org/10.37586/2686-8636-2-2020-115-130
10. Herr M., Sirven N., Grondin H., Pichetti S., Sermet C. Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French population. Eur J Clin Pharmacol. 2017 Sep; 73(9): 1165–1172. DOI: 10.1007/ s00228-017-2276-5. Epub 2017 Jun 11. PMID: 28601963.
11. Saum K.U., Schöttker B., Meid A.D., Holleczek B., Haefeli W.E., Hauer K., Brenner H. Is Polypharmacy Associated with Frailty in Older People? Results From the ESTHER Cohort Study. J Am Geriatr Soc. 2017 Feb; 65(2): e27–e32. DOI: 10.1111/jgs.14718. Epub 2016 Dec 26. PMID: 28024089.
12. de Groot M.H., van Campen J.P., Kosse N.M., de Vries O.J., Beijnen J.H., Lamoth C.J. The Association of Medication-Use and Frailty-Related Factors with Gait Performance in Older Patients. PLoS One. 2016 Feb 22; 11(2): e0149888. DOI: 10.1371/journal. pone.0149888. PMID: 26901048; PMCID: PMC4763331.
13. Warwick J., Falaschetti E., Rockwood K., Mitnitski A., Thijs L., Beckett N., Bulpitt C., Peters R. No evidence that frailty modifies the positive impact of antihypertensive treatment in very elderly people: an investigation of the impact of frailty upon treatment effect in the HYpertension in the Very Elderly Trial (HYVET) study, a doubleblind, placebo-controlled study of antihypertensives in people with hypertension aged 80 and over. BMC Med. 2015 Apr 9; 13: 78. DOI: 10.1186/s12916-015-0328-1. PMID: 25880068; PMCID: PMC4404571.
14. Katsila T., Patrinos G.P., Kardamakis D. Searching for Clinically Relevant Biomarkers in Geriatric Oncology. Biomed Res Int. 2018 Feb 18; 2018: 3793154. DOI: 10.1155/2018/3793154. PMID: 29670897; PMCID: PMC5835288.
15. Хосева Е.Н., Морозова Т.Е. Проблемные аспекты развития системы фармаконадзора в Российской Федерации на современном этапе (обзор). Качественная Клиническая Практика. 2013; (3): 40–45.
Review
For citations:
Tkacheva O.N., Sychev D.A., Malaya I.P., Burmistrov V.A., Vergazova E.K., Galeeva A.A., Gordeev I.G., Dmitriev V.A., Zhuravleva M.V., Zyryanov S.K., Kotovskaya Yu.V., Naumov A.V., Nedogoda S.V., Runikhina N.K., Teplova-Bareisha К.Е., Frolova E.V., Khokhlov A.L. Consensus expert opinion on key items in planning and designing clinical trials in geriatric patients. Russian Journal of Geriatric Medicine. 2021;(4):398-402. (In Russ.) https://doi.org/10.37586/2686-8636-4-2021-398-402